Anti-tumor properties of cis-resveratrol methylated analogs in metastatic mouse melanoma cells

被引:25
|
作者
Morris, Valery L. [1 ]
Toseef, Tayyaba [1 ]
Nazumudeen, Fathima B. [1 ]
Rivoira, Christian [1 ]
Spatafora, Carmela [2 ]
Tringali, Corrado [2 ]
Rotenberg, Susan A. [1 ]
机构
[1] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA
[2] Univ Catania, Dipartimento Sci Chim, I-95125 Catania, Italy
关键词
Polymethoxystilbenes; Cell motility; Proliferation; beta-tubulin; PHIP; Anti-cancer; PROTEIN-KINASE-C; B-16; MELANOMA; INHIBITION; ACTIVATION; TUBULIN; GROWTH; APOPTOSIS; MIGRATION; STILBENE; PATHWAY;
D O I
10.1007/s11010-014-2316-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Resveratrol (E-3,5,4'-trihydroxystilbene) is a polyphenol found in red wine that has been shown to have multiple anti-cancer properties. Although cis-(Z)-and trans-(E)-isomers of resveratrol occur in nature, the cis form is not biologically active. However, methylation at key positions of the cis form results in more potent anti-cancer properties. This study determined that synthetic cis-polymethoxystilbenes (methylated analogs of cis-resveratrol) inhibited cancer-related phenotypes of metastatic B16 F10 and nonmetastatic B16 F1 mouse melanoma cells. In contrast with cis-or trans-resveratrol and trans-polymethoxystilbene which were ineffective at 10 mu M, cis-polymethoxystilbenes inhibited motility and proliferation of melanoma cells with low micromolar specificity (IC50 < 10 mu M). Inhibitory effects by cis-polymethoxystilbenes were significantly stronger with B16 F10 cells and were accompanied by decreased expression of beta-tubulin and pleckstrin homology domain-interacting protein, a marker of metastatic B16 cells. Thus, cis-polymethoxystilbenes have potential as chemotherapeutic agents for metastatic melanoma.
引用
收藏
页码:83 / 91
页数:9
相关论文
共 50 条
  • [31] Ultrasound Enhanced Anti-tumor Effect of Temozolomide in Glioblastoma Cells and Glioblastoma Mouse Model
    Jie Xue
    Yuanyuan Wu
    Na Liu
    Cellular and Molecular Bioengineering, 2019, 12 : 99 - 106
  • [32] Tyrosinase in melanoma inhibits anti-tumor activity of PD-1 deficient T cells
    Rong Huang
    Yingbin Wang
    Haitao Teng
    Mengjun Xu
    Kexin He
    Yingzhuo Shen
    Guo Guo
    Xinyu Feng
    Tianhan Li
    Binhui Zhou
    Marc Bajenoff
    Toby Lawrence
    Yinming Liang
    Liaoxun Lu
    Lichen Zhang
    BMC Biology, 23 (1)
  • [33] Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma
    Yang, Yuqi
    Wang, Sijia
    Wang, Xiang-xu
    Guo, Sen
    Wang, Huina
    Shi, Qiong
    Tian, Yangzi
    Wang, Hao
    Zhao, Tao
    Zhang, Hengxiang
    Zhang, Baolu
    Gao, Tianwen
    Li, Chunying
    Yi, Xiuli
    Guo, Weinan
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [34] Oleanolic acid derivative Dex-OA has potent anti-tumor and anti-metastatic activity on osteosarcoma cells in vitro and in vivo
    Hua, Yingqi
    Zhang, Zhiyu
    Li, Jianxin
    Li, Quan
    Hu, Shuo
    Li, Jian
    Sun, Mengxiong
    Cai, Zhengdong
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (02) : 258 - 265
  • [35] Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma
    Zimmerman, Sarah M.
    Suh, Erin
    Smith, Sofia R.
    Souroullas, George P.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (11)
  • [36] Chidamide augment sorafenib-derived anti-tumor activities in human osteosarcoma cells lines and xenograft mouse model
    Yuan, Ying
    Li, Daifeng
    Hu, Xiang
    Li, Yizhou
    Yi, Wanrong
    Li, Pengcheng
    Zhao, Yong
    Li, Zonghuan
    Yu, Aiming
    Jian, Chao
    Yu, Aixi
    MEDICAL ONCOLOGY, 2022, 39 (05)
  • [37] A study on anti-tumor immunity induced by gene-modified melanoma B16 cells
    Fang, Lijuan
    Wang, Kemin
    Liu, Xia
    Zhang, Leilei
    Zhang, Xingqian
    Qian, Li
    Lu, Jian
    Qian, Guanxiang
    Ge, Shengfang
    ONCOLOGY REPORTS, 2008, 19 (06) : 1589 - 1595
  • [38] Anti-tumor properties of FoxO1 in YD-9 oral squamous cell carcinoma cells
    Kim, Yu Gyung
    Seong, Chaeeun
    Cho, Kyoung-Ah
    Lee, Sang Min
    Kim, Tae-Jun
    Kim, Hyeon Ji
    Cho, Jin-Hwa
    Jung, Won
    Jang, Sungil
    Shin, Jae-Cheon
    Lee, Kyung-Ha
    Byun, Jin-Seok
    Kim, Do-Yeon
    ONCOLOGY REPORTS, 2023, 49 (06)
  • [39] RECENT ADVANCES IN THE ROLE OF AMP-ACTIVATED PROTEIN KINASE IN METABOLIC REPROGRAMMING OF METASTATIC CANCER CELLS: TARGETING CELLULAR BIOENERGETICS AND BIOSYNTHETIC PATHWAYS FOR ANTI-TUMOR TREATMENT
    Tyszka-Czochara, M.
    Konieczny, P.
    Majka, M.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2018, 69 (03): : 337 - 349
  • [40] The Immunogenicity and Anti-tumor Efficacy of a Rationally Designed Neoantigen Vaccine for B16F10 Mouse Melanoma
    Zhang, Yan
    Lin, Zhibing
    Wan, Yuhua
    Cai, Huaman
    Deng, Li
    Li, Rongxiu
    FRONTIERS IN IMMUNOLOGY, 2019, 10